Table of Contents

Articles

• You have access

  Isolation, Characterization and Differential Gene Expression of Multispecific Organic Anion Transporter 2 in Mice

  Yasuna Kobayashi, Naomi Ohshiro, Akiko Shibusawa, Tadanori Sasaki, Shogo Tokuyama, Takashi Sekine, Hitoshi Endou and Toshinori Yamamoto

  Molecular Pharmacology July 2002, 62 (1) 7-14; DOI: https://doi.org/10.1124/mol.62.1.7
• You have access

  Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine_1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor

  Marı́a L. López-Rodrı́guez, Bruno Vicente, Xavier Deupi, Sergio Barrondo, Mireia Olivella, M. José Morcillo, Bellinda Behamú, Juan A. Ballesteros, Joan Sallés and Leonardo Pardo

  Molecular Pharmacology July 2002, 62 (1) 15-21; DOI: https://doi.org/10.1124/mol.62.1.15
• You have access

  Inhibition of the Mitochondrial Permeability Transition by the Nonimmunosuppressive Cyclosporin Derivative NIM811

  Peter C. Waldmeier, Jean-Jacques Feldtrauer, Ting Qian and John J. Lemasters

  Molecular Pharmacology July 2002, 62 (1) 22-29; DOI: https://doi.org/10.1124/mol.62.1.22
• You have access

  NK1 Receptor Fused to β-Arrestin Displays a Single-Component, High-Affinity Molecular Phenotype

  Lene Martini, Hanne Hastrup, Birgitte Holst, Alberto Fraile-Ramos, Mark Marsh and Thue W. Schwartz

  Molecular Pharmacology July 2002, 62 (1) 30-37; DOI: https://doi.org/10.1124/mol.62.1.30
• You have access

  Molecular Modeling and Site-Specific Mutagenesis of the Histamine-Binding Site of the Histamine H₄ Receptor

  Niu Shin, Elizabeth Coates, Nicholas J. Murgolo, Kelley L. Morse, Marvin Bayne, Catherine D. Strader and Frederick J. Monsma

  Molecular Pharmacology July 2002, 62 (1) 38-47; DOI: https://doi.org/10.1124/mol.62.1.38
• You have access

  Novel Tarantula Toxins for Subtypes of Voltage-Dependent Potassium Channels in the Kv2 and Kv4 Subfamilies

  Pierre Escoubas, Sylvie Diochot, Marie-Louise Célérier, Terumi Nakajima and Michel Lazdunski

  Molecular Pharmacology July 2002, 62 (1) 48-57; DOI: https://doi.org/10.1124/mol.62.1.48
• You have access

  Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542

  N. J. Laping, E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan and B. A. Olson

  Molecular Pharmacology July 2002, 62 (1) 58-64; DOI: https://doi.org/10.1124/mol.62.1.58
• You have access

  SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7

  Gareth J. Inman, Francisco J. Nicolás, James F. Callahan, John D. Harling, Laramie M. Gaster, Alastair D. Reith, Nicholas J. Laping and Caroline S. Hill

  Molecular Pharmacology July 2002, 62 (1) 65-74; DOI: https://doi.org/10.1124/mol.62.1.65
• You have access

  Molecular Mechanisms for the Activation of Voltage-Independent Ca²⁺ Channels by Endothelin-1 in Chinese Hamster Ovary Cells Stably Expressing Human Endothelin_A Receptors

  Yoshifumi Kawanabe, Yasuo Okamoto, Soichi Miwa, Nobuo Hashimoto and Tomoh Masaki

  Molecular Pharmacology July 2002, 62 (1) 75-80; DOI: https://doi.org/10.1124/mol.62.1.75
• You have access

  Selective Allosteric Enhancement of Agonist Binding and Function at Human A₃ Adenosine Receptors by a Series of Imidazoquinoline Derivatives

  Zhan-Guo Gao, Seong Gon Kim, Kelly A. Soltysiak, Neli Melman, Adriaan P. IJzerman and Kenneth A. Jacobson

  Molecular Pharmacology July 2002, 62 (1) 81-89; DOI: https://doi.org/10.1124/mol.62.1.81
• You have access

  Aurintricarboxylic Acid Protects against Cell Death Caused by Lipopolysaccharide in Macrophages by Decreasing Inducible Nitric-Oxide Synthase Induction via IκB Kinase, Extracellular Signal-Regulated Kinase, and p38 Mitogen-Activated Protein Kinase Inhibition

  Chin-Ju Tsi, Yee Chao, Ching-Wen Chen and Wan Wan Lin

  Molecular Pharmacology July 2002, 62 (1) 90-101; DOI: https://doi.org/10.1124/mol.62.1.90
• You have access

  The Effect of Thiopurine Methyltransferase Expression on Sensitivity to Thiopurine Drugs

  Sally A. Coulthard, Linda A. Hogarth, Margaret Little, Elizabeth C. Matheson, Christopher P. F. Redfern, Lynne Minto and Andrew G. Hall

  Molecular Pharmacology July 2002, 62 (1) 102-109; DOI: https://doi.org/10.1124/mol.62.1.102
• You have access

  Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byN ^G-Amino-l-arginine in Vitro and in Vivo

  Jennifer L. Vuletich, Ezra R. Lowe, Suree Jianmongkol, Yasuhiko Kamada, Ute M. Kent, Andrew T. Bender, Damon R. Demady, Paul F. Hollenberg and Yoichi Osawa

  Molecular Pharmacology July 2002, 62 (1) 110-118; DOI: https://doi.org/10.1124/mol.62.1.110
• You have access

  Classic D1 Dopamine Receptor AntagonistR-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) Directly Inhibits G Protein-Coupled Inwardly Rectifying Potassium Channels

  Eldo V. Kuzhikandathil and Gerry S. Oxford

  Molecular Pharmacology July 2002, 62 (1) 119-126; DOI: https://doi.org/10.1124/mol.62.1.119
• You have access

  Molecular Determinants of Intracellular pH Modulation of Human Kv1.4 N-Type Inactivation

  Benzy J. Padanilam, Tong Lu, Toshinori Hoshi, Beena A. Padanilam, Erwin F. Shibata and Hon-Chi Lee

  Molecular Pharmacology July 2002, 62 (1) 127-134; DOI: https://doi.org/10.1124/mol.62.1.127
• You have access

  Integrated Channel Plasticity Contributes to Alcohol Tolerance in Neurohypophysial Terminals

  Thomas K. Knott, Alejandro M. Dopico, Govindan Dayanithi, José Lemos and Steven N. Treistman

  Molecular Pharmacology July 2002, 62 (1) 135-142; DOI: https://doi.org/10.1124/mol.62.1.135
• You have access

  Activation of the Antitumor Agent Aminoflavone (NSC 686288) Is Mediated by Induction of Tumor Cell Cytochrome P450 1A1/1A2

  Mary J. Kuffel, Jennifer C. Schroeder, Lori J. Pobst, Stephen Naylor, Joel M. Reid, Scott H. Kaufmann and Matthew M. Ames

  Molecular Pharmacology July 2002, 62 (1) 143-153; DOI: https://doi.org/10.1124/mol.62.1.143
• You have access

  The Homeodomain Pbx2-Prep1 Complex Modulates Hepatocyte Nuclear Factor 1α-Mediated Activation of theUDP-Glucuronosyltransferase 2B17 Gene

  Philip A. Gregory and Peter I. Mackenzie

  Molecular Pharmacology July 2002, 62 (1) 154-161; DOI: https://doi.org/10.1124/mol.62.1.154
• You have access

  Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism

  Yvonne S. Lin, Amy L. S. Dowling, Sean D. Quigley, Federico M. Farin, Jiong Zhang, Jatinder Lamba, Erin G. Schuetz and Kenneth E. Thummel

  Molecular Pharmacology July 2002, 62 (1) 162-172; DOI: https://doi.org/10.1124/mol.62.1.162
• You have access

  The Unique Property of the CC Chemokine Regakine-1 to Synergize with Other Plasma-Derived Inflammatory Mediators in Neutrophil Chemotaxis Does Not Reside in Its NH₂-Terminal Structure

  Mieke Gouwy, Sofie Struyf, Frank Mahieu, Willy Put, Paul Proost and Jo Van Damme

  Molecular Pharmacology July 2002, 62 (1) 173-180; DOI: https://doi.org/10.1124/mol.62.1.173
• You have access

  [¹²⁵I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I₁Imidazoline Receptors

  Hugues Greney, Dragan Urosevic, Stephan Schann, Laurence Dupuy, Véronique Bruban, Jean-Daniel Ehrhardt, Pascal Bousquet and Monique Dontenwill

  Molecular Pharmacology July 2002, 62 (1) 181-191; DOI: https://doi.org/10.1124/mol.62.1.181